Healthcare

Brexit has had an undeniable impact, leading to workforce shortages, long term uncertainty over regulation and new administrative processes. Trade deals offer an opportunity to address some key issues facing the sector and therefore help UK healthcare grow post-Brexit but witnesses also highlighted concerns about how future trade deals could negatively impact healthcare in the UK.

The report highlights the importance of regulatory alignment with the EU and maintains that healthcare should be an important aspect of future trade negotiations, whilst keeping the privatisation of the NHS off the negotiating table.

Witnesses

PETER ELLINGWORTH, Chief Executive, Association of British HealthTech Industries

MARTHA McCAREY, Brexit and Health Researcher, Nuffield Trust

TAMARA HERVEY, Jean Monnet Professor of EU Law, City University London

KATE LING, Senior European Policy Manager, NHS Confederation

DR NICK MANN, GP, Keep our NHS Public